Skip to main content
. 2020 Apr 14;16:281–286. doi: 10.2147/TCRM.S247437

Table 2.

Incidence and Severity of Cough in Patients Receiving Nalbuphine or Placebo

Group N
(n=105)
Group C
(n=105)
P value
Incidence (n%) 0 30 (28.5%) 0.000
Severity (n%)
Mild 0 8 (7.6%) 0.004
Moderate 0 10 (9.5%) 0.001
Severe 0 12 (11.4%) 0.000

Note: Values are expressed as numbers (percentage).